Prospects of Parathyroid Hormone in Therapeutic Intervention

Chilakapati, Rajeenkanna; Mannully, Chanchal Thomas; Pulicherla, K. K.

doi:10.1007/s10989-018-9744-3

Published: 16 August 2018

Prospects of Parathyroid Hormone in Therapeutic Intervention

Rajeenkanna Chilakapati¹,
Chanchal Thomas Mannully² &
K. K. Pulicherla³

International Journal of Peptide Research and Therapeutics volume 25, pages 961–977 (2019)Cite this article

212 Accesses
1 Citations
Metrics details

Abstract

Biologically active peptides and proteins have wide applications as therapeutic agents as well as diagnostics. Parathyroid hormone (PTH), a polypeptide secreted by the parathyroid chief cells has been found to be an effective therapeutic protein for the treatment of osteoporosis. PTH as an anabolic agent and a potent regulator of ionized calcium and phosphate plays a pivotal role in maintaining active vitamin D metabolite levels in the circulating blood. Though licensed PTH is available in two forms as teriparatide having 1–34 amino acids and intact hormone having 1–84 aminoacids, due to short plasma half-life and low activity, their therapeutic purpose has been limited. Protein engineering approaches like PEGylation, conjugation with antibody complexes, and fusion proteins as well as amino terminal modification of intact or truncated PTH has helped to develop PTH and its modified analogs with improved therapeutic value and multitude functions in various fields of medicine. This review covers the significant role of PTH in osteoblast signaling mechanism, regulation of PTH secretion and its transcription, modifications in PTH along with its functional efficacy in different medical areas.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 39.95

Price includes VAT (USA)
Tax calculation will be finalised during checkout.

References

Abdallah EA, Said RN, Mosallam DS, Moawad EM, Kamal NM, Fathallah MGD (2016) Serial serum alkaline phosphatase as an early biomarker for osteopenia of prematurity. Medicine 95(37):e4837. https://doi.org/10.1097/MD.0000000000004837
CAS Article PubMed PubMed Central Google Scholar
Agas D, Marchetti L, Capitani M, Sabbieti MG (2013) The dual face of parathyroid hormone and prostaglandins in the osteoimmune system. Am J Physiol Endocrinol Metab 305(10):E1185–E1194. https://doi.org/10.1152/ajpendo.00290.2013
CAS Article PubMed Google Scholar
Andersson P, Rydberg E, Willenheimer R (2004) Primary hyperparathyroidism and heart disease-a review. Eur Heart J 25(20):1776–1787. https://doi.org/10.1016/j.ehj.2004.07.010
CAS Article PubMed Google Scholar
Arnold A, Horst SA, Gardella TJ, Baba H, Levine MA, Kronenberg HM (1990) Mutation of the signal peptide-encoding region of the preproparathyroid hormone gene in familial isolated hypoparathyroidism. J Clin Invest 86(4):1084–1087. https://doi.org/10.1172/JCI114811
CAS Article PubMed PubMed Central Google Scholar
Augustine M, Horwitz MJ (2013) Parathyroid hormone and parathyroid hormone-related protein analogs as therapies for osteoporosis. Curr Osteoporos Rep 11(4):400–406. https://doi.org/10.1007/s11914-013-0171-2
Article PubMed Google Scholar
Bakhtiari N, Bayat ZA, Sagharidouz S, Vaez M (2017) Overexpression of recombinant human teriparatide, rhPTH (1–34) in Escherichia coli: an innovative gene fusion approach. Avicenna J Med Biotechnol 9(1):19–22
PubMed PubMed Central Google Scholar
Ballen KK, Shpall EJ, Avigan D, Yeap BY, Fisher DC, McDermott K, Dey BR, Attar E, McAfee S, Konopleva M, Antin JH, Spitzer TR (2007) Phase I trial of parathyroid hormone to facilitate stem cell mobilization. Biol Blood Marrow Transplant 13(7):838–843. https://doi.org/10.1016/j.bbmt.2007.03.007
CAS Article PubMed Google Scholar
Ballen K, Mendizabal AM, Cutler C, Politikos I, Jamieson K, Shpall EJ, Dey BR, Attar E, McAfee S, Delaney C, McCarthy P et al (2012) Phase II trial of parathyroid hormone after double umbilical cord blood transplantation. Biol Blood Marrow Transplant 18(12):1851–1858. https://doi.org/10.1016/j.bbmt.2012.06.016
CAS Article PubMed PubMed Central Google Scholar
Beck L, Karaplis AC, Amizuka N, Hewson AS, Ozawa H, Tenenhouse HS (1998) Targeted inactivation of Npt2 in mice leads to severe renal phosphate wasting, hypercalciuria, and skeletal abnormalities. Proc Natl Acad Sci 95(9):5372–5377. https://doi.org/10.1073/pnas.95.9.5372
CAS Article PubMed Google Scholar
Bibby SR, Meir A, Fairbank JC, Urban JP (2002) Cell viability and the physical environment in the scoliotic intervertebral disc. Stud Health Technol Inform 91:419–421
PubMed Google Scholar
Bilezikian JP (2008) Combination anabolic and antiresorptive therapy for osteoporosis: opening the anabolic window. Curr Osteoporos Rep 6(1):24–30. https://doi.org/10.1007/s11914-008-0005-9
Article PubMed Google Scholar
Bonewald LF, Johnson ML (2008) Osteocytes, mechanosensing and Wnt signaling. Bone 42(4):606–615. https://doi.org/10.1016/j.bone.2007.12.224
CAS Article PubMed PubMed Central Google Scholar
Boos N, Weissbach S, Rohrbach H, Weiler C, Spratt KF, Nerlich AG (2002) Classification of age-related changes in lumbar intervertebral discs: 2002 Volvo Award in basic science. Spine 27(23):2631–2644. https://doi.org/10.1097/01.BRS.0000035304.27153.5B
Article PubMed Google Scholar
Boskey L, Coleman R (2010) Aging and bone. J Dent Res 89(12):1333–1348. https://doi.org/10.1177/0022034510377791
CAS Article PubMed PubMed Central Google Scholar
Brewer HB Jr, Fairwell T, Rittel W, Littledike T, Arnaud CD (1974) Recent studies on the chemistry of human, bovine and porcine parathyroid hormones. Am J Med 56(6):759–766. https://doi.org/10.1016/0002-9343(74)90803-1
CAS Article PubMed Google Scholar
Brown EM, Gamba G, Riccardi D, Lombardi M, Butters R, Kifor O, Sun A, Hediger MA, Lytton J, Hebert SC (1993) Cloning and characterization of an extracellular Ca²⁺-sensing receptor from bovine parathyroid. Nature 366(6455):575–580. https://doi.org/10.1038/366575a0
CAS Article PubMed Google Scholar
Canalis E, Giustina A, Bilezikian JP (2007) Mechanisms of anabolic therapies for osteoporosis. N Engl J Med 357(9):905–916. https://doi.org/10.1056/NEJMra067395
CAS Article PubMed Google Scholar
Chan HL, McCauley LK (2013) Parathyroid hormone applications in the craniofacial skeleton. J Dent Res 92(1):18–25. https://doi.org/10.1177/0022034512464779
CAS Article PubMed PubMed Central Google Scholar
Chiavistelli S, Giustina A, Mazziotti G (2015) Parathyroid hormone pulsatility: physiological and clinical aspects. Bone Res 3:14049. https://doi.org/10.1038/boneres.2014.49
CAS Article PubMed PubMed Central Google Scholar
Crenshaw TD, Rortvedt LA, Hassen Z (2011) Triennial growth symposium: a novel pathway for vitamin D-mediated phosphate homeostasis: implications for skeleton growth and mineralization. J Anim Sci 89(7):1957–1964. https://doi.org/10.2527/jas.2010-3411
CAS Article PubMed Google Scholar
Crockett JC, Rogers MJ, Coxon FP, Hocking LJ, Helfrich MH (2011) Bone remodelling at a glance. J Cell Sci 124(7):991–998. https://doi.org/10.1242/jcs.063032
CAS Article PubMed Google Scholar
Datta NS (2011) Osteoporotic fracture and parathyroid hormone. World J Orthop 2(8):67. https://doi.org/10.5312/wjo.v2.i8.67
Article PubMed PubMed Central Google Scholar
Dempster DW, Raisz LG (2015) Bone physiology: bone cells, modeling, and remodeling. In: Holick MF, Nieves JW (eds) Nutrition and bone health. Nutrition and health, 2nd edn. Humana Press, New York, pp 37–56. https://doi.org/10.1007/978-1-4939-2001-3_3
Chapter Google Scholar
Dempster DW, Zhou H, Recker RR, Brown JP, Bolognese MA, Recknor CP, Kendler DL, Lewiecki EM, Hanley DA, Rao DS, Miller PD (2012) Skeletal histomorphometry in subjects on teriparatide or zoledronic acid therapy (SHOTZ) study: a randomized controlled trial. J Clin Endocrinol Metab 97(8):2799–2808. https://doi.org/10.1210/jc.2012-1262
CAS Article PubMed Google Scholar
Ertl DA, Stary S, Streubel B, Raimann A, Haeusler G (2012) A novel homozygous mutation in the parathyroid hormone gene (PTH) in a girl with isolated hypoparathyroidism. Bone 51(3):629–632. https://doi.org/10.1016/j.bone.2012.06.009
CAS Article PubMed Google Scholar
Freemont AJ (2008) The cellular pathobiology of the degenerate intervertebral disc and discogenic back pain. Rheumatology 48(1):5–10. https://doi.org/10.1093/rheumatology/ken396
Article PubMed Google Scholar
Fu XY, Tong WY, Wei DZ (2005) Extracellular production of human parathyroid hormone as a thioredoxin fusion form in Escherichia coli by chemical permeabilization combined with heat treatment. Biotechnol Progr 21(5):1429–1435. https://doi.org/10.1021/bp050137z
CAS Article Google Scholar
Fu Q, Manolagas SC, O’Brien CA (2006) Parathyroid hormone controls receptor activator of NF-κB ligand gene expression via a distant transcriptional enhancer. Mol Cell Biol 26(17):6453–6468. https://doi.org/10.1128/MCB.00356-06
CAS Article PubMed PubMed Central Google Scholar
Fukagawa M, Nakanishi S, Fujii H, Hamada Y, Abe T (2006) Regulation of parathyroid function in chronic kidney disease (CKD). Clin Exp Nephrol 10(3):175–179. https://doi.org/10.1007/s10157-006-0432-9
CAS Article PubMed Google Scholar
Garrett G, Sardiwal S, Lamb EJ, Goldsmith DJ (2013) PTH—a particularly tricky hormone: why measure it at all in kidney patients? Clin J Am Soc Nephrol 8(2):299–312. https://doi.org/10.2215/CJN.09580911
CAS Article PubMed Google Scholar
Gesty-Palmer D, Chen M, Reiter E, Ahn S, Nelson CD, Wang S, Eckhardt AE, Cowan CL, Spurney RF, Luttrell LM, Lefkowitz RJ (2006) Distinct β-arrestin-and G protein-dependent pathways for parathyroid hormone receptor-stimulated ERK1/2 activation. J Biol Chem 281(16):10856–10864. https://doi.org/10.1074/jbc.M513380200
CAS Article PubMed Google Scholar
Goodman WG, Juppner H, Salusky IB, Sherrard DJ (2003) Parathyroid hormone (PTH), PTH-derived peptides, and new PTH assays in renal osteodystrophy. Kidney Int 63(1):1–11. https://doi.org/10.1046/j.1523-1755.2003.00700.x
CAS Article PubMed Google Scholar
Gopalakrishnan R, Suttamanatwong S, Carlson AE, Franceschi RT (2005) Role of matrix Gla protein in parathyroid hormone inhibition of osteoblast mineralization. Cells Tissues Organs 181(3–4):166–175. https://doi.org/10.1159/000091378
CAS Article PubMed Google Scholar
Guo J, Khatri A, Maeda A, Potts JT Jr, Jüppner H, Gardella TJ (2017) Prolonged pharmacokinetic and pharmacodynamic actions of a pegylated parathyroid hormone (1–34) peptide fragment. J Bone Miner Res 32(1):86–98. https://doi.org/10.1002/jbmr.2917
CAS Article PubMed Google Scholar
Hart TC, Hart PS (2009) Genetic studies of craniofacial anomalies: clinical implications and applications. Orthod Craniofac Res 12(3):212–220. https://doi.org/10.1111/j.1601-6343.2009.01455.x
CAS Article PubMed PubMed Central Google Scholar
Hasegawa H, Nagano N, Urakawa I, Yamazaki Y, Iijima K, Fujita T, Yamashita T, Fukumoto S, Shimada T (2010) Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease. Kidney Int 78(10):975–980. https://doi.org/10.1038/ki.2010.313
CAS Article PubMed Google Scholar
Hayman JA, Danks JA, Ebeling PR, Moseley JM, Kemp BE, Martin TJ (1989) Expression of parathyroid hormone related protein in normal skin and in tumours of skin and skin appendages. J Pathol 158(4):293–296. https://doi.org/10.1002/path.1711580405
CAS Article PubMed Google Scholar
Hofer AM, Brown EM (2003) Calcium: extracellular calcium sensing and signalling. Nat Rev Mol Cell Biol 4(7):530–538. https://doi.org/10.1038/nrm1154
CAS Article PubMed Google Scholar
Holick MF, Ray S, Chen TC, Tian X, Persons KS (1994) A parathyroid hormone antagonist stimulates epidermal proliferation and hair growth in mice. Proc Natl Acad Sci USA 91(17):8014–8016. https://doi.org/10.1073/pnas.91.17.8014
CAS Article PubMed Google Scholar
Hristova GI, Jarzem P, Ouellet JA, Roughley PJ, Epure LM, Antoniou J, Mwale F (2011) Calcification in human intervertebral disc degeneration and scoliosis. J Orthop Res 29(12):1888–1895. https://doi.org/10.1002/jor.21456
Article PubMed Google Scholar
Isakova T, Wolf MS (2010) FGF23 or PTH: which comes first in CKD? Kidney Int 78(10):947–949. https://doi.org/10.1038/ki.2010.281
CAS Article PubMed Google Scholar
Jacobson JA, Yanoso-Scholl L, Reynolds DG, Dadali T, Bradica G, Bukata S, Puzas EJ, Zuscik MJ, Rosier R, O’Keefe RJ, Schwarz EM, Awad HA (2010) Teriparatide therapy and beta-tricalcium phosphate enhance scaffold reconstruction of mouse femoral defects. Tissue Eng A 17(3–4):389–398. https://doi.org/10.1089/ten.TEA.2010.0115
Article Google Scholar
Jia H, Ma J, Lv J, Ma X, Xu W, Yang Y, Tian A, Wang Y, Sun L, Xu L, Fu L, Zhao J (2016) Oestrogen and parathyroid hormone alleviate lumbar intervertebral disc degeneration in ovariectomized rats and enhance Wnt/β-catenin pathway activity. Sci Rep 6:27521. https://doi.org/10.1038/srep27521
CAS Article PubMed PubMed Central Google Scholar
Jin L, Briggs SL, Chandrasekhar S, Chirgadze NY, Clawson DK, Schevitz RW, Smiley DL, Tashjian AH, Zhang F (2000) Crystal structure of human parathyroid hormone 1–34 at 0.9-Å resolution. J Biol Chem 275(35):27238–27244. https://doi.org/10.1074/jbc.M001134200
CAS Article PubMed Google Scholar
Johansson H (2015) The Uppsala anatomist Ivar Sandstorm and the parathyroid gland. Ups J Med Sci 120(2):72–77. https://doi.org/10.3109/03009734.2015.1027426
Article PubMed PubMed Central Google Scholar
Jung RE, Cochran DL, Domken O, Seibl R, Jones AA, Buser D, Hammerle CH (2007a) The effect of matrix bound parathyroid hormone on bone regeneration. Clin Oral Implants Res 18(3):319–325. https://doi.org/10.1111/j.1600-0501.2007.01342.x
Article PubMed Google Scholar
Jung RE, Hammerle CH, Kokovic V, Weber FE (2007b) Bone regeneration using a synthetic matrix containing a parathyroid hormone peptide combined with a grafting material. Int J Oral Maxillofac Implants 22(2):258–266
PubMed Google Scholar
Jüppner H, Gardella TJ, Brown EM, Kronenberg HM, Potts JT Jr (2001) Parathyroid hormone and parathyroid hormone-related peptide in the regulation of calcium homeostasis and bone development. In: De Groot LJ, Jameson JL (eds) Endocrinology, vol 2, 4th edn. Elsevier, Philadelphia, pp 969–998
Google Scholar
Kafetzis ID, Diamantopoulos A, Christakis I, Leoutsakos B (2011) The history of the parathyroid glands. Hormones 10(1):80–84. https://doi.org/10.14310/horm.2002.1297
Article PubMed Google Scholar
Kalra S, Baruah MP, Sahay R, Sawhney K (2013) The history of parathyroid endocrinology. Indian J Endocrinol Metab 17(2):320–322. https://doi.org/10.4103/2230-8210.109703
Article PubMed PubMed Central Google Scholar
Karsenty G, Kronenberg HM, Settembre C (2009) Genetic control of bone formation. Annu Rev Cell Dev Biol 25:629–648. https://doi.org/10.1146/annurev.cellbio.042308.113308
CAS Article PubMed Google Scholar
Kilav R, Silver J, Naveh-Many T (2000) A conserved cis-acting element in the parathyroid hormone 3′-untranslated region is sufficient for regulation of RNA stability by calcium and phosphate. J Biol Chem 276(12):8727–8733. https://doi.org/10.1074/jbc.M005471200
Article PubMed Google Scholar
Kilav R, Silver J, Naveh-Many T (2005) Regulation of parathyroid hormone mRNA stability by calcium and phosphate. In: Naveh-Many T (ed) Molecular biology of the parathyroid. Molecular biology intelligence unit. Springer, Boston, pp 57–67. https://doi.org/10.1007/0-387-27530-4_5
Chapter Google Scholar
Koh AJ, Demiralp B, Neiva KG, Hooten J, Nohutcu RM, Shim H, Datta NS, Taichman RS, McCauley LK (2005) Cells of the osteoclast lineage as mediators of the anabolic actions of parathyroid hormone in bone. Endocrinology 146(11):4584–4596. https://doi.org/10.1210/en.2005-0333
CAS Article PubMed Google Scholar
Koizumi M, Komaba H, Fukagawa M (2013) Parathyroid function in chronic kidney disease: role of FGF23-Klotho axis. In: Razzaque MS (ed) Phosphate and vitamin D in chronic kidney disease, contributions to nephrolology, vol 180. Karger, Basel, pp 110–123. https://doi.org/10.1159/000346791
Chapter Google Scholar
Komaba H, Fukagawa M (2010) FGF23-parathyroid interaction: implications in chronic kidney disease. Kidney Int 77(4):292–298. https://doi.org/10.1038/ki.2009.466
CAS Article PubMed Google Scholar
Komrakova M, Stuermer EK, Werner C, Wicke M, Kolios L, Sehmisch S, Tezval M, Daub F, Martens T, Witzenhausen P, Dullin C, Stuermer KM (2010) Effect of human parathyroid hormone hPTH (1–34) applied at different regimes on fracture healing and muscle in ovariectomized and healthy rats. Bone 47(3):480–492. https://doi.org/10.1016/j.bone.2010.05.013
CAS Article PubMed Google Scholar
Kostenuik PJ, Ferrari S, Pierroz D, Bouxsein M, Morony S, Warmington KS, Adamu S, Geng Z, Grisanti M, Shalhoub V, Martin S, Biddlecome G, Shimamoto G, Boone T, Shen V, Lacey D (2007) Infrequent delivery of a long-acting PTH-Fc fusion protein has potent anabolic effects on cortical and cancellous bone. J Bone Miner Res 22(10):1534–1547. https://doi.org/10.1359/jbmr.070616
CAS Article PubMed Google Scholar
Kumar R, Thompson JR (2011) The regulation of parathyroid hormone secretion and synthesis. J Am Soc Nephrol 22(2):216–224. https://doi.org/10.1681/ASN.2010020186
CAS Article PubMed Google Scholar
Kurosu H, Ogawa Y, Miyoshi M, Yamamoto M, Nandi A, Rosenblatt KP, Baum MG, Schiavi S, Hu MC, Moe OW, Kuro-o M (2006) Regulation of fibroblast growth factor-23 signaling by Klotho. J Biol Chem 281(10):6120–6123. https://doi.org/10.1074/jbc.C500457200
CAS Article PubMed PubMed Central Google Scholar
Kwan JT, Beer JC, Noonan K, Cunningham J (1993) Parathyroid sensing of the direction of change of calcium in uremia. Kidney Int 43(5):1104–1109. https://doi.org/10.1038/ki.1993.155
CAS Article PubMed Google Scholar
Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H et al (1998) Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93(2):165–176. https://doi.org/10.1016/S0092-8674(00)81569-X
CAS Article PubMed Google Scholar
Lagassé HD, Alexaki A, Simhadri VL, Katagiri NH, Jankowski W, Sauna ZE, Kimchi-Sarfaty C (2017) Recent advances in (therapeutic protein) drug development. F1000Res 6:113. https://doi.org/10.12688/f1000research.9970.1
CAS Article PubMed PubMed Central Google Scholar
Lane NE, Sanchez S, Modin GW, Genant HK, Pierini E, Arnaud CD (1998) Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled clinical trial. J Clin Invest 102(8):1627–1633. https://doi.org/10.1172/JCI3914
CAS Article PubMed PubMed Central Google Scholar
Leader B, Baca QJ, Golan DE (2008) Protein therapeutics: a summary and pharmacological classification. Nat Rev Drug Discov 7(1):21–39. https://doi.org/10.1038/nrd2399
CAS Article PubMed Google Scholar
Leder BZ, Tsai JN, Uihlein AV, Burnett-Bowie SA, Zhu Y, Foley K, Lee H, Neer RM (2014) Two years of Denosumab and teriparatide administration in postmenopausal women with osteoporosis (The DATA Extension Study): a randomized controlled trial. J Clin Endocrinol Metab 99(5):1694–1700. https://doi.org/10.1210/jc.2013-4440
CAS Article PubMed PubMed Central Google Scholar
Lee SH, Lee S, Youn YS, Na DH, Chae SY, Byun Y, Lee KC (2005) Synthesis, characterization, and pharmacokinetic studies of PEGylated glucagon-like peptide-1. Bioconjug Chem 16(2):377–382. https://doi.org/10.1021/bc049735&%23x002B;
CAS Article PubMed Google Scholar
Lee S, Mannstadt M, Guo J, Kim SM, Yi HS, Khatri A, Dean T, Okazaki M, Gardella TJ, Jüppner H (2015) A homozygous [Cys25] PTH (1–84) mutation that impairs PTH/PTHrP receptor activation defines a novel form of hypoparathyroidism. J Bone Miner Res 30(10):1803–1813. https://doi.org/10.1002/jbmr.2532
CAS Article PubMed PubMed Central Google Scholar
Liu CY, Li X, Chen WY, Chang LC, Chen YF, Chen HL, Sun YS, Lai HY, Huang EW (2014) PEGylation site-dependent structural heterogeneity study of monoPEGylated human parathyroid hormone fragment hPTH (1–34). Langmuir 30(38):11421–11427. https://doi.org/10.1021/la501689d
CAS Article PubMed Google Scholar
Loreto C, Musumeci G, Castorina A, Loreto C, Martinez G (2011) Degenerative disc disease of herniated intervertebral discs is associated with extracellular matrix remodeling, vimentin-positive cells and cell death. Ann Anat 193(2):156–162. https://doi.org/10.1016/j.aanat.2010.12.001
CAS Article PubMed Google Scholar
Lourida I, Thompson-Coon J, Dickens CM, Soni M, Kuźma E, Kos K, Llewellyn DJ (2015) Parathyroid hormone, cognitive function and dementia: a systematic review. PLoS ONE 10(5):e0127574. https://doi.org/10.1371/journal.pone.0127574
CAS Article PubMed PubMed Central Google Scholar
MacCallum WG, Voegtlin C (1976) On the relation of the parathyroid to calcium metabolism and the nature of tetany. Nutr Rev 34(7):212–213. https://doi.org/10.1111/j.1753-4887.1976.tb05769.x
CAS Article PubMed Google Scholar
Madiraju P, Gawri R, Wang H, Antoniou J, Mwale F (2013) Mechanism of parathyroid hormone-mediated suppression of calcification markers in human intervertebral disc cells. Eur Cell Mater 25:268–283. https://doi.org/10.22203/eCM.v025a19
CAS Article PubMed Google Scholar
Majeska RJ, Rodan GA (1982) Alkaline phosphatase inhibition by parathyroid hormone and isoproterenol in a clonal rat osteosarcoma cell line. Possible mediation by cyclic AMP. Calcif Tissue Int 34(1):59–66. https://doi.org/10.1007/BF02411210
CAS Article PubMed Google Scholar
Malberti F, Farina M, Imbasciati E (1999) The PTH-calcium curve and the set point of calcium in primary and secondary hyperparathyroidism. Nephrol Dial Transplant 14(10):2398–2406. https://doi.org/10.1093/ndt/14.10.2398
CAS Article PubMed Google Scholar
Mayer GP, Hurst JG (1978) The sigmoidal relationship between parathyroid hormone secretion rate and plasma calcium concentration in calves. Endocrinology 102(4):1036–1042. https://doi.org/10.1210/endo-102-4-1036
CAS Article PubMed Google Scholar
Monier-Faugere MC, Geng Z, Mawad H, Friedler RM, Gao P, Cantor TL, Malluche HH (2001) Improved assessment of bone turnover by the PTH-(1–84)/large C-PTH fragments ratio in ESRD patients. Kidney Int 60(4):1460–1468. https://doi.org/10.1046/j.1523-1755.2001.00949.x
CAS Article PubMed Google Scholar
Murray TM, Rao LG, Divieti P, Bringhurst FR (2005) Parathyroid hormone secretion and action: evidence for discrete receptors for the carboxyl-terminal region and related biological actions of carboxyl- terminal ligands. Endocr Rev 26(1):78–113. https://doi.org/10.1210/er.2003-0024
CAS Article PubMed Google Scholar
Nechama M, Uchida T, Yosef-Levi IR, Silver J, Naveh-Many T (2009) The peptidyl-prolyl isomerise Pin1 determines parathyroid hormone mRNA levels and stability in rat models of secondary hyperparathyroidism. J Clin Invest 119(10):3102–3114. https://doi.org/10.1172/JCI39522
CAS Article PubMed PubMed Central Google Scholar
Nordenström J, Marcus R (2015) A history of the parathyroid glands and their secretory product, parathyroid hormone. In: Bilezikian JP, Marcus R, Levine M, Marcocci C, Silverberg SJ, Potts J (eds) The parathyroids, 3rd edn. Elsevier, Burlington, pp 1–20
Google Scholar
O’Brien CA (2010) Control of RANKL gene expression. Bone 46(4):911–919. https://doi.org/10.1016/j.bone.2009.08.050
CAS Article PubMed Google Scholar
Okumura K, Saito M, Yoshizawa Y, Munakata H, Isogai E, Miura I, Wakana S, Yamaguchi M, Shitara H, Taya C, Karaplis AC, Kominami R, Wakabayashi Y (2017) The parathyroid hormone regulates skin tumour susceptibility in mice. Sci Rep 7(1):11208
Article Google Scholar
Orimo H (2010) The mechanism of mineralization and the role of alkaline phosphatase in health and disease. J Nippon Med Sch 77(1):4–12. https://doi.org/10.1038/s41598-017-11561-x
CAS Article PubMed Google Scholar
Palmer SC, Hayen A, Macaskill P, Pellegrini F, Craig JC, Elder GJ, Strippoli GF (2011) Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis. JAMA 305(11):1119–1127. https://doi.org/10.1001/jama.2011.308
CAS Article PubMed Google Scholar
Parkinson DB, Thakker RV (1992) A donor splice site mutation in the parathyroid hormone gene is associated with autosomal recessive hypoparathyroidism. Nat Genet 1(2):149–152. https://doi.org/10.1038/ng0592-149
CAS Article PubMed Google Scholar
Potts JT Jr, Kronenberg HM, Habener JF, Rich A (1980) Biosynthesis of parathyroid hormone. Ann N Y Acad Sci 343(1):38–55. https://doi.org/10.1111/j.1749-6632.1980.tb47241.x
CAS Article PubMed Google Scholar
Potts JT (2005) Parathyroid hormone: past and present. J Endocrinol 187(3):311–325. https://doi.org/10.1677/joe.1.06057
CAS Article PubMed Google Scholar
Ratner M (2015) Shire bags NPS, including newly approved biologic for hypoparathyroidism. Nat Biotechnol 33(3):226–227
CAS Article Google Scholar
Reis A, Hecht W, Gröger R, Böhm I, Cooper DN, Lindenmaier W, Mayer H, Schmidtke J (1990) Cloning and sequence analysis of the human parathyroid hormone gene region. Hum Genet 84(2):119–124. https://doi.org/10.1007/BF00208924
CAS Article PubMed Google Scholar
Reynolds DG, Takahata M, Lerner AL, O’Keefe RJ, Schwarz EM, Awad HA (2011) Teriparatide therapy enhances devitalized femoral allograft osseointegration and biomechanics in a murine model. Bone 48(3):562–570. https://doi.org/10.1016/j.bone.2010.10.003
CAS Article PubMed Google Scholar
Rowshan HH, Parham MA, Baur DA, McEntee RD, Cauley E, Carriere DT, Wood JC, Demsar WJ, Pizarro JM (2010) Effect of intermittent systemic administration of recombinant parathyroid hormone (1–34) on mandibular fracture healing in rats. J Oral Maxillofac Surg 68(2):260–267. https://doi.org/10.1016/j.joms.2009.09.045
Article PubMed Google Scholar
Salvesen HA (1923) Studies on the physiology of the parathyroids. Proc Soc Exp Biol Med 20(4):204–210. https://doi.org/10.3181/00379727-20-101
Article Google Scholar
Sato E, Muto J, Zhang LJ, Adase CA, Sanford JA, Takahashi T, Nakatsuji T, Usdin TB, Gallo RL (2016) The parathyroid hormone second receptor PTH2R and its ligand tuberoinfundibular peptide of 39 residues TIP39 regulate intracellular calcium and infuence keratinocyte diferentiation. J Invest Dermatol 136(7):1449–1459. https://doi.org/10.1016/j.jid.2016.02.814
CAS Article PubMed PubMed Central Google Scholar
Schaefer F (2003) Pulsatile parathyroid hormone secretion in health and disease. In: Chadwick DJ, Goode JA (eds) Mechanisms and biological significance of pulsatile hormone secretion: Novartis foundation symposium 227, vol. 227. Wiley, Chichester, pp 225–239
Google Scholar
Shen ZJ, Esnault S, Malter JS (2005) The peptidyl-prolyl isomerase Pin1 regulates the stability of granulocyte-macrophage colony- stimulating factor mRNA in activated eosinophils. Nat Immunol 6(12):1280–1287. https://doi.org/10.1038/ni1266
CAS Article PubMed Google Scholar
Shen ZJ, Esnault S, Rosenthal LA, Szakaly RJ, Sorkness RL, Westmark PR, Sandor M, Malter JS (2008) Pin1 regulates TGF-β1 production by activated human and murine eosinophils and contributes to allergic lung fibrosis. J Clin Invest 118(2):479–490. https://doi.org/10.1172/JCI32789
CAS Article PubMed PubMed Central Google Scholar
Shimizu M, Potts JT Jr, Gardella TJ (2000) Minimization of parathyroid hormone. Novel amino-terminal parathyroid hormone fragments with enhanced potency in activating the type-1 parathyroid hormone receptor. J Biol Chem 275(29):21836–21843. https://doi.org/10.1074/jbc.M909861199
CAS Article PubMed Google Scholar
Shinagawa Y, Inoue T, Katsushima T, Kiguchi T, Ikenogami T, Ogawa N, Fukuda K, Hirata K, Harada K, Takagi M, Nakagawa T et al (2010) Discovery of a potent and short-acting oral calcilytic with a pulsatile secretion of parathyroid hormone. ACS Med Chem Lett 2(3):238–242. https://doi.org/10.1021/ml100268k
CAS Article PubMed PubMed Central Google Scholar
Silver J, Naveh-Many T (2009) Phosphate and the parathyroid. Kid Int 75(9):898–905. https://doi.org/10.1038/ki.2008.642
CAS Article Google Scholar
Sneddon WB, Barry EL, Coutermarsh BA, Gesek FA, Liu F, Friedman PA (1998) Regulation of renal parathyroid hormone receptor expression by 1, 25-dihydroxyvitamin D3 and retinoic acid. Cell Physiol Biochem 8(5):261–277. https://doi.org/10.1159/000016288
CAS Article PubMed Google Scholar
Sosa MH, Diez AP (2007) Parathyroid hormone in the treatment of osteoporosis. Annales de Medicina Interna 24(2):87–97
Google Scholar
Sunthornthepvarakul T, Churesigaew S, Ngowngarmratana S (1999) A novel mutation of the signal peptide of the preproparathyroid hormone gene associated with autosomal recessive familial isolated hypoparathyroidism. J Clin Endocrinol Metab 84(10):3792–3796. https://doi.org/10.1210/jcem.84.10.6070
CAS Article PubMed Google Scholar
Swarthout JT, D’Alonzo RC, Selvamurugan N, Partridge NC (2002) Parathyroid hormone-dependent signalling pathways regulating genes in bone cells. Gene 282(1–2):1–17. https://doi.org/10.1016/S0378-1119(01)00798-3
CAS Article PubMed Google Scholar
Teitelbaum SL (2007) Osteoclasts: what do they do and how do they do it? Am J Pathol 170(2):427–435. https://doi.org/10.2353/ajpath.2007.060834
CAS Article PubMed PubMed Central Google Scholar
Tella SH, Kommalapati A, Correa R (2017) Profile of abaloparatide and its potential in the treatment of postmenopausal osteoporosis. Cureus 9(5):e1300. https://doi.org/10.7759/cureus.1300
Article PubMed PubMed Central Google Scholar
Tong G, Meng Y, Hao S, Hu S, He Y, Yan W, Yang D (2017) Parathyroid hormone activates phospholipase C (PLC)-independent protein kinase C signalling pathway via protein kinase A (PKA)-dependent mechanism: a new defined signalling route would induce alternative consideration to previous conceptions. Med Sci Monit 23:1896–1906. https://doi.org/10.12659/MSM.903699
CAS Article PubMed PubMed Central Google Scholar
Urakawa I, Yamazaki Y, Shimada T, Iijima K, Hasegawa H, Okawa K, Fujita T, Fukumoto S, Yamashita T (2006) Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature 444(7120):770–774. https://doi.org/10.1038/nature05315
CAS Article PubMed Google Scholar
Urban JP, Roberts S (2003) Degeneration of the intervertebral disc. Arthritis Res Ther 5(3):120–130. https://doi.org/10.1186/ar629
Article PubMed PubMed Central Google Scholar
Usmani SS, Bedi G, Sameul JS, Singh S, Kalra S, Kumar P, Ahuja AA, Sharma M, Gautam A, Raghava GP (2017) THPdb: database of FDA-approved peptide and protein therapeutics. PLoS ONE 12(7):e0181748. https://doi.org/10.1371/journal.pone.0181748
CAS Article PubMed PubMed Central Google Scholar
Vasicek TJ, McDevitt BE, Freeman MW, Fennick BJ, Hendy GN, Potts JT Jr, Rich A, Kronenberg HM (1983) Nucleotide sequence of the human parathyroid hormone gene. Proc Natl Acad Sci USA 80(8):2127–2131. https://doi.org/10.1073/pnas.80.8.2127
CAS Article PubMed Google Scholar
Verheijen MH, Defize LH (1997) Parathyroid hormone activates mitogen-activated protein kinase via a cAMP-mediated pathway independent of Ras. J Biol Chem 272(6):3423–3429. https://doi.org/10.1074/jbc.272.6.3423
CAS Article PubMed Google Scholar
Widler L (2011) Calcilytics: antagonists of the calcium-sensing receptor for the treatment of osteoporosis. Future Med Chem 3(5):535–547. https://doi.org/10.4155/fmc.11.17
CAS Article PubMed Google Scholar
Wu M, Shen Q, Yang Y, Zhang S, Qu W, Chen J, Sun H, Chen S (2013) Disruption of YPS1 and PEP4 genes reduces proteolytic degradation of secreted HSA/PTH in Pichia pastoris GS115. J Ind Microbiol Biotechnol 40(6):589–599. https://doi.org/10.1007/s10295-013-1264-8
CAS Article PubMed PubMed Central Google Scholar
Yamashita J, McCauley LK, Van Poznak C (2010) Updates on osteonecrosis of the jaw. Curr Opin Support Palliat Care 4(3):200–206. https://doi.org/10.1097/SPC.0b013e32833d303b
Article PubMed PubMed Central Google Scholar
Youn YS, Na DH, Lee KC (2007) High-yield production of biologically active mono-PEGylated salmon calcitonin by site-specific PEGylation. J Control Release 117(3):371–379. https://doi.org/10.1016/j.jconrel.2006.11.013
CAS Article PubMed Google Scholar

Download references

Author information

Authors and Affiliations

Department of Biotechnology, Acharya Nagarjuna University, Nagarjuna Nagar, Guntur, Andhra Pradesh, 522510, India
Rajeenkanna Chilakapati
Vellore Institute of Technology, Vellore, Tamil Nadu, 632014, India
Chanchal Thomas Mannully
Department of Science & Technology, Ministry of Science & Technology, Government of India, New Mehrauli Road, New Delhi, 110016, India
K. K. Pulicherla

Authors

Rajeenkanna Chilakapati
View author publications
You can also search for this author in PubMed Google Scholar
Chanchal Thomas Mannully
View author publications
You can also search for this author in PubMed Google Scholar
K. K. Pulicherla
View author publications
You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to K. K. Pulicherla.

Ethics declarations

Conflict of interest

There was no conflict of interest among the authors.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Chilakapati, R., Mannully, C.T. & Pulicherla, K.K. Prospects of Parathyroid Hormone in Therapeutic Intervention. Int J Pept Res Ther 25, 961–977 (2019). https://doi.org/10.1007/s10989-018-9744-3

Download citation

Accepted: 13 August 2018
Published: 16 August 2018
Issue Date: 01 September 2019
DOI: https://doi.org/10.1007/s10989-018-9744-3

Keywords

Parathyroid hormone
Therapeutic protein
Calcium
Phosphate
Vitamin D
Osteoblast signaling